Amount and intensity of daily total physical activity, step count and risk of incident cancer in the UK Biobank.
Shreves AH. et al, (2025), Br J Sports Med
Prediagnostic Plasma Nutrimetabolomics and Prostate Cancer Risk: A Nested Case-Control Analysis Within the EPIC Study.
Almanza-Aguilera E. et al, (2024), Cancers (Basel), 16
Circulating inflammatory and immune response proteins and endometrial cancer risk: a nested case-control study and Mendelian randomization analyses.
Wang SE. et al, (2024), EBioMedicine, 108
Cluster effect for SNP-SNP interaction pairs for predicting complex traits.
Lin H-Y. et al, (2024), Sci Rep, 14
Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomics.
Desai TA. et al, (2024), EBioMedicine, 105
Identifying proteomic risk factors for cancer using prospective and exome analyses of 1463 circulating proteins and risk of 19 cancers in the UK Biobank.
Papier K. et al, (2024), Nat Commun, 15
RE: Exploring the cross-cancer effect of circulating proteins and discovering potential intervention targets for 13 site-specific cancers.
Yarmolinsky J. et al, (2024), J Natl Cancer Inst, 116, 764 - 765
Identifying therapeutic targets for cancer among 2074 circulating proteins and risk of nine cancers.
Smith-Byrne K. et al, (2024), Nat Commun, 15
Circulating endogenous sex steroids and risk of differentiated thyroid carcinoma in men and women.
Rinaldi S. et al, (2024), Int J Cancer
Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis.
Yarmolinsky J. et al, (2024), EBioMedicine, 100
Observational and genetic associations between cardiorespiratory fitness and cancer: a UK Biobank and international consortia study.
Watts EL. et al, (2024), Br J Cancer, 130, 114 - 124
Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.
Wang A. et al, (2023), Nat Genet, 55, 2065 - 2074
Dose-response of accelerometer-measured physical activity, step count, and cancer risk in the UK Biobank: a prospective cohort analysis.
Shreves AH. et al, (2023), Lancet, 402 Suppl 1
Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate Cancer.
Darst BF. et al, (2023), JAMA Oncol, 9, 1514 - 1524
Prediagnostic selenium status, selenoprotein gene variants and association with breast cancer risk in a european cohort study.
Hughes DJ. et al, (2023), Free Radic Biol Med
Dietary amino acids and risk of stroke subtypes: a prospective analysis of 356,000 participants in seven European countries.
Tong TYN. et al, (2023), Eur J Nutr
Associations of intakes of total protein, protein from dairy sources, and dietary calcium with risks of colorectal, breast, and prostate cancer: a prospective analysis in UK Biobank.
Watling CZ. et al, (2023), Br J Cancer, 129, 636 - 647
Intake of the Total, Classes, and Subclasses of (Poly)Phenols and Risk of Prostate Cancer: A Prospective Analysis of the EPIC Study.
Almanza-Aguilera E. et al, (2023), Cancers (Basel), 15